1. De Mendonça A, Vincent JL, Suter PM, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000;26:915.
2. Schwilk B, Wiedeck H, Stein B, et al. Epidemiology of acute renal failure and outcome of haemodiafiltration in intensive Care. Intensive Care Med. 1997;23:1204.
4. Bellomo R. Defining, quantifying, and classifying acute renal failure. Crit Care Clin. 2005;21:223.
5. Marenzi G, Bartorelli AL. Recent advances in the prevention of radiocontrast-induced nephropathy. Curr Opin Crit Care. 2004;10(6):505.
6. Stacul F, Adam A, Becker CR. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol. 2006;98(6A):59K.
7. Meschi M, Detrenis S, Musini S. Facts and fallacies concerning the prevention of contrast medium-induced nephropathy. Crit Care Med. 2006;34(8):2060.
8. Meiera P, Vogtb P, Blanca E. Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron. 2001;87:199.
9. Ronco C, Bellomo R, Ricci Z. Continuous arteriovenous hemofiltration in critically ill patients. Nephrol Dial Transplant. 2001;16(suppl 5):67.
10. Manns M, Sigler MH, Teehan BP. Intradialytic renal haemodynamics—potential consequences for the management of the patient with acute renal failure. Nephrol Dial Transplant. 1997;12:865.
11. Lauer A, Saccaggi A, Ronco C. Continuous arteriovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics. Ann Intern Med. 1983;99(4):455.
12. Kellum JA, Angus DC, Johnson JP. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med. 2002;28(1):29.
13. Jacka MJ, Ivancinova X, Gibney RT. Continuous renal replacement therapy improves renal recovery from acute renal failure. Can J Anaesth. 2005;52(3):327.
14. Waldrop J, Ciraulo DL, Milner TP. A comparison of continuous renal replacement therapy to intermittent dialysis in the management of renal insufficiency in the acutely ill surgical patient. Am Surg. 2005;71(1):36.
15. Tominaga GT, Ingegno M, Ceraldi C, et al. Vascular complications of continuous arteriovenous hemofiltration in trauma patients. J Trauma. 1993;35(2):285.
16. Bellomo R, Parkin G, Love J. A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. Am J Kidney Dis. 1993;21(4):400.
17. Storck M, Hartl WH, Zimmerer E. Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet. 1991; 337(8739):452.
18. Kierdorf H. Continuous versus intermittent treatment: clinical results in acute renal failure. Contrib Nephrol. 1991;93:1.
19. Monchi M, Berghmans D, Ledoux D. Citrate vs. heparin
for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med.
20. Bernard G, Vincent JL, Laterre PF. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699.
21. de Pont AC
, Bouman CS, de Jonge E. Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis. Intensive Care Med.
22. Uchino S, Bellomo R, Morimatsu H. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med. 2009;37(9):2576.
23. Finkel K, Podoll W, Amber S. Comment: discontinuation of continuous renal replacement therapy: when is enough enough? Crit Care Med. 2009;37(9):2664.
24. Choi G, Gomersall C, Tian Q. Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med. 2009;37(7):2268.
25. De Vriese AS, Colardyn FA, Philippe JJ. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999;10(4):846.
26. Piccinni P, Dan M, Barbacini S. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med. 2006;32(1):80.